A round of Series A financing has pulled in $6 million for Israel-based Theranica Bio-electronics, a medtech company that makes advanced electroceuticals for treating common illnesses such as migraine. The company intends to use the proceeds to secure regulatory approval for its first product for acute migraine treatment, as well as to advance the product toward mass production.
Sign up for AdvaMed SmartBrief
Medical technology news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.